Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: J Nutr Biochem. 2017 Apr 19;47:63–74. doi: 10.1016/j.jnutbio.2017.04.009

Figure 1. Dietary scheme.

Figure 1

Design for treatment groups showing maternal diet (E10.5-PN21) and post-weaning diet (PN21-week 14). (A) The effect of VA deficiency on diet-induced obesity (DIO), (B) the effect of the maternal diet on DIO, (C) and the effect of VA deficiency on a low fat base diet (LF12). Composition of each diet is shown in Supplementary Table 1.